Search
-
Money
In this issue of What the Future, read how digital currencies, financial inclusion and the sharing economy are reshaping our relationship with money. Ipsos' exclusive global research reveals key insights for brands and media in this transformative landscape.
-
Consumer confidence: Global index stability betrays divergent trends at the local level
Sentiment shifting significantly in half of the countries surveyed – downward for some, upward for others.
-
The State of Reputation: Today’s Context; Tomorrow’s Expectations
Hear corporate reputation research insights exploring the impacts of COVID, Diversity and Inclusion, ESG, Internal Communications, Supply Chain issues, and more.
-
Sports
NFTs, digital media and gambling are increasingly influencing sports and how we will consume them in the future. We explore what this will mean for fans, brands and media.
-
U.S. consumer confidence up slightly this week
Yet Americans remain less optimistic than they were before the pandemic
-
America the Uncertain: November Briefing Highlights
Key highlights from November’s America the Uncertain webinar, a briefing from the Ipsos political polling team on data and trends shaping American politics.
-
Are We Ready to Share Again?
Revisit our recorded webinar to hear new research exploring current and potentially future shared mobility trends.
-
Global Trends 2021: Aftershocks and continuity
Seven in ten globally now say they tend to buy brands that reflect their personal values and that business leaders have a responsibility to speak out on social issues.
-
Ipsos Update - November 2021
Our monthly round-up of research and thinking from Ipsos around the world includes new global reports on the topics of health, trustworthiness, and infrastructure. Also discover the latest white papers on empathy, insights, and retail trends.
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.